Alan A. Musso - Jan 26, 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Chief Financial Officer
Signature
/s/ Alan Musso
Stock symbol
FULC
Transactions as of
Jan 26, 2024
Transactions value $
$0
Form type
4
Date filed
1/30/2024, 09:05 PM
Previous filing
Jan 19, 2024
Next filing
Aug 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +100K $0.00 100K Jan 26, 2024 Common Stock 100K $6.95 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on January 26, 2024 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2024, subject to the reporting person's continued service on each such vesting date.